RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

There is a certain tunnelvision to the Cortex shareholder view--like it's only happening to them, and that there is some unique reason for it that must be ferreted out. I keep pointing out that there is evidence to the contrary. You respond with a comment about boosterism.

I am surprised that Cortex went down this much--and that Targacept went down this much--and that Neurogen went down this much. Now that I think of it, Cypress Biosciences went down a lot after its milnacipran Phase III boost. Color me surprised, but to label it as a Cortex-centric phenomenon is (and I am not singling you out individually) to miss the larger point. And it's being missed repeatedly, so I am starting to get the impression that there is a degree of masochism going on here. I'm unhappy about the price drop, it makes me anxious, but I don't get much of a thrill trying to figure out a scenario that belongs to Cortex and Cortex alone, when in fact it has plenty of company. Life is hard enough without adding more pain without necessity or reason.

NeuroInvestment